NuvinkaDx Achieves Milestones for GeneProof and ALPCO's Diagnostic Solutions NuvinkaDx announces groundbreaking achievements for its companies GeneProof and ALPCO, enhancing diagnostic testing capabilities in Europe and Canada.

NuvinkaDx Achieves Milestones for GeneProof and ALPCO's Diagnostic Solutions #United_States #Salem #ALPCO #NuvinkaDx #GeneProof

#ALPCO has an extensive selection of human & animal #immunoassays for #diabetes #obesity & other #metabolic disorders biomarkers

Optimized for range, sensitivity, sample type, & time in multiple formats inc colorimetric, chemiluminescent #ELISA, RIA

🔗 www.stratech.co.uk/our-partners...

ALPCO Launches Innovative Calprotectin Assay and Begins Clinical Trials in the US ALPCO expands its GI diagnostic solutions with the European launch of a Calprotectin assay, and initiates a clinical trial for a new automated version in the US, enhancing diagnostic accuracy.

ALPCO Launches Innovative Calprotectin Assay and Begins Clinical Trials in the US #United_States #Salem #Calprotectin_Assay #ALPCO #NuvinkaDx

We are proud to provide expert assays for gastroenterology allergy, infectious disease, #immunology, #diabetes, #obesity, & #endocrinology from #alpco a global leader in #immunodiagnostics & molecular diagnostics to the UK life science & clinical research community
www.stratech.co.uk/our-partners...